Healthigg | Health Bookmarks | Medicine News

Health experts say it has potential to greatly improve treatment of the respiratory disease

A tuberculosis test, called Xpert® MTB/RIF, can successfully identify 98% of all culture-confirmed TB cases, including more than 90% of those with smear-negative disease, a study published in NEJM (New England Journal of Medicine) reveals. The test is highly sensitive for tuberculosis as well as drug resistance to the powerful anti-TB drug rifampicin (RIF) in low resource settings, the authors write. The study revealed that the Xpert® MTB/RIF was accurate in more than 97% of patients with drug resistance...

Early detection and treatment of Chronic Kidney Disease are important to keep kidney disease from Early Stage Kidney Disease to Kidney Failure. Some tests can detect early kidney disease through the differences between the normal and the abnormal level. They are:

1. Blood pressure measurement. A patient with high blood pressure has a great chance to have Chronic Kidney Disease.

Two new reviews suggest accurate diagnosis is clinically important because treatments for Lewy body and Parkinson disease dementias differ from treatments for Alzheimer's disease. Medscape Medical News (Source: Medscape Today Headlines)

In clinic, in most of time, microalbumin is used to monitor the occurrence of kidney disease. The test of microalbumin is the most allergic and reliable index which is used to diagnose kidney disease in the early stage.

In clinic, in most of time, microalbumin is used to monitor the occurrence of kidney disease. The test of microalbumin is the most allergic and reliable index which is used to diagnose kidney disease in the early stage.

which can diagnose tuberculosis in one hour, potentially helping to curb the spread of the disease, a British health agency said in a study Wednesday. The "ultra-rapid" test is far quicker than traditional methods, which can take up to eight weeks and

Professor Clive Ballard says the new test for Alzheimer's disease is 95% accurate for people with memory problems (Source: BBC News | Health | UK Edition)

Decoding the DNA of a woman who died of acute myeloid leukemia (AML) has led researchers at Washington University School of Medicine in St. Louis to a gene that they found to be commonly altered in many patients who died quickly of the disease. The findings, if confirmed in larger studies, suggest that a diagnostic test for mutations in the gene could identify AML patients who need more aggressive treatment right from the start. The new discovery also provides a concrete target for developing improved therapies against AML, a fast-moving blood cancer that kills 9,000 Americans annually...